These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 10878292)

  • 1. Mechanisms of action of methotrexate.
    Genestier L; Paillot R; Quemeneur L; Izeradjene K; Revillard JP
    Immunopharmacology; 2000 May; 47(2-3):247-57. PubMed ID: 10878292
    [No Abstract]   [Full Text] [Related]  

  • 2. Methotrexate: anti-inflammatory or immunosuppressive?
    van de Putte LB; Boerbooms AM; Barrera P; Kerstens PJ; Jeurissen ME
    Clin Exp Rheumatol; 1993; 11 Suppl 8():S97-9. PubMed ID: 8324961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Methotrexate therapy in rheumatoid arthritis].
    Ichikawa Y; Shinozawa T; Yoshida T; Akama H; Kameda H
    Ryumachi; 1991 Oct; 31(5):544-53. PubMed ID: 1767348
    [No Abstract]   [Full Text] [Related]  

  • 4. [The investigation and progress of the cellular and molecular biological mechanisms of Tripterygium wilfordii in treating rheumatoid arthritis].
    Chen Z; Li RL; Tu SH
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Feb; 29(2):183-6. PubMed ID: 19382484
    [No Abstract]   [Full Text] [Related]  

  • 5. Serious liver disease in a patient receiving methotrexate and leflunomide.
    Weinblatt ME; Dixon JA; Falchuk KR
    Arthritis Rheum; 2000 Nov; 43(11):2609-11. PubMed ID: 11083289
    [No Abstract]   [Full Text] [Related]  

  • 6. New treatments for rheumatoid arthritis. Available and upcoming slow-acting antirheumatic drugs.
    Fye KH
    Postgrad Med; 1999 Oct; 106(4):82-5, 88-90, 92. PubMed ID: 10533510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial.
    Saevarsdottir S; Wallin H; Seddighzadeh M; Ernestam S; Geborek P; Petersson IF; Bratt J; van Vollenhoven RF;
    Ann Rheum Dis; 2011 Mar; 70(3):469-75. PubMed ID: 21149498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of rheumatoid arthritis].
    Bolten WW
    MMW Fortschr Med; 2008 Aug; 150(32-35):50-3; quiz 54. PubMed ID: 19006884
    [No Abstract]   [Full Text] [Related]  

  • 9. Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis?
    Fairbanks LD; Rückemann K; Qiu Y; Hawrylowicz CM; Richards DF; Swaminathan R; Kirschbaum B; Simmonds HA
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):143-52. PubMed ID: 10432311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of leflunomide in active rheumatoid arthritis.
    Smolen JS; Emery P
    Rheumatology (Oxford); 2000 Jun; 39 Suppl 1():48-56. PubMed ID: 11001380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte phenotype studies of rheumatoid arthritis patients treated with methotrexate.
    Lacki JK; Mackiewicz SH; Wiktorowicz KE
    Arch Immunol Ther Exp (Warsz); 1994; 42(4):287-90. PubMed ID: 7487368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].
    Schnabel A; Gross WL
    Dtsch Med Wochenschr; 2003 Jan; 128(4):147-9. PubMed ID: 12589584
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of homeopathic preparation Vozraston in the therapy of patients with rheumatoid arthritis.
    Noskov SM; Snigireva AV; Dolgova LN; Somova MA; Polyakov DP
    Bull Exp Biol Med; 2003 Jan; 135 Suppl 7():94-5. PubMed ID: 12949664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of immunosuppressive effect of low-dose oral methotrexate on lymphocytes in rheumatoid arthritis.
    Martínez-Osuna P; Zwolinska JB; Sikes DH; Cory JG; Silveira LH; Jara LJ; Espinoza LR
    Clin Exp Rheumatol; 1993; 11(3):249-53. PubMed ID: 8353979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis.
    Cutolo M; Sulli A; Pizzorni C; Seriolo B; Straub RH
    Ann Rheum Dis; 2001 Aug; 60(8):729-35. PubMed ID: 11454634
    [No Abstract]   [Full Text] [Related]  

  • 16. The place of methotrexate in the treatment of rheumatoid arthritis. Introduction.
    Hoffmeister RT
    Semin Arthritis Rheum; 1991 Oct; 21(2 Suppl 1):1-3. PubMed ID: 1749944
    [No Abstract]   [Full Text] [Related]  

  • 17. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.
    Ranganath VK; Furst DE
    Clin Geriatr Med; 2005 Aug; 21(3):649-69, viii. PubMed ID: 15911212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenging the therapeutic pyramid: a new look at treatment strategies for rheumatoid arthritis.
    Wilske KR; Healey LA
    J Rheumatol Suppl; 1990 Nov; 25():4-7. PubMed ID: 2273521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Methotrexate and non-steroidal anti-inflammatory agent combination in rheumatoid arthritis].
    Bertin P; Carpentier N; Vergne P; Bonnet C; Bannwarth B; Dehais J; Treves R
    Therapie; 1997; 52(2):133-7. PubMed ID: 9231508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate and leflunomide combination therapy for patients with active rheumatoid arthritis.
    Mroczkowski PJ; Weinblatt ME; Kremer JM
    Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S66-8. PubMed ID: 10589360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.